Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1186

1.

Systems Analysis of Physical Absorption of CO2 in Ionic Liquids for Pre-Combustion Carbon Capture.

Zhai H, Rubin ES.

Environ Sci Technol. 2018 Apr 17;52(8):4996-5004. doi: 10.1021/acs.est.8b00411. Epub 2018 Apr 9.

PMID:
29589925
2.

DNA indicative of human bocaviruses detected in non-human primates in the Democratic Republic of the Congo.

Kumakamba C, Ngay Lukusa I, Mbala Kingebeni P, N'Kawa F, Atibu Losoma J, Mulembakani PM, Makuwa M, Muyembe Tamfum JJ, Belais R, Gillis A, Harris S, Rimoin AW, Hoff NA, Fair JN, Monagin C, Ayukekbong J, Rubin EM, Wolfe ND, Lange CE.

J Gen Virol. 2018 Mar 27. doi: 10.1099/jgv.0.001048. [Epub ahead of print]

PMID:
29583115
3.

Cultivation and sequencing of rumen microbiome members from the Hungate1000 Collection.

Seshadri R, Leahy SC, Attwood GT, Teh KH, Lambie SC, Cookson AL, Eloe-Fadrosh EA, Pavlopoulos GA, Hadjithomas M, Varghese NJ, Paez-Espino D; Hungate1000 project collaborators, Perry R, Henderson G, Creevey CJ, Terrapon N, Lapebie P, Drula E, Lombard V, Rubin E, Kyrpides NC, Henrissat B, Woyke T, Ivanova NN, Kelly WJ.

Nat Biotechnol. 2018 Apr;36(4):359-367. doi: 10.1038/nbt.4110. Epub 2018 Mar 19.

PMID:
29553575
4.

Residual Symptoms Following Treatment for Depression in Patients with Coronary Heart Disease.

Carney RM, Freedland KE, Steinmeyer BC, Rubin EH, Rich MW.

Psychosom Med. 2018 Mar 8. doi: 10.1097/PSY.0000000000000570. [Epub ahead of print]

PMID:
29521883
5.

Development of MK-8353, an orally administered ERK1/2 inhibitor, in patients with advanced solid tumors.

Moschos SJ, Sullivan RJ, Hwu WJ, Ramanathan RK, Adjei AA, Fong PC, Shapira-Frommer R, Tawbi HA, Rubino J, Rush TS 3rd, Zhang D, Miselis NR, Samatar AA, Chun P, Rubin EH, Schiller J, Long BJ, Dayananth P, Carr D, Kirschmeier P, Bishop WR, Deng Y, Cooper A, Shipps GW, Moreno BH, Robert L, Ribas A, Flaherty KT.

JCI Insight. 2018 Feb 22;3(4). pii: 92352. doi: 10.1172/jci.insight.92352. [Epub ahead of print]

6.

Misunderstanding the goals of animal research.

Rubin EJ, Fortune SM.

BMJ. 2018 Feb 21;360:k759. doi: 10.1136/bmj.k759. No abstract available.

PMID:
29467126
7.

TB diagnosis from the Dark Ages to fluorescence.

Rubin EJ.

Nat Microbiol. 2018 Mar;3(3):268-269. doi: 10.1038/s41564-018-0118-6. No abstract available.

PMID:
29463926
8.

Dissecting Cellulitis of the Scalp: A Rare Dermatological Manifestation of Crohn's Disease.

Syed TA, Ul Abideen Asad Z, Salem G, Garg K, Rubin E, Agudelo N.

ACG Case Rep J. 2018 Jan 31;5:e8. doi: 10.14309/crj.2018.8. eCollection 2018.

9.

Identification of genes required for Mycobacterium abscessus growth in vivo with a prominent role of the ESX-4 locus.

Laencina L, Dubois V, Le Moigne V, Viljoen A, Majlessi L, Pritchard J, Bernut A, Piel L, Roux AL, Gaillard JL, Lombard B, Loew D, Rubin EJ, Brosch R, Kremer L, Herrmann JL, Girard-Misguich F.

Proc Natl Acad Sci U S A. 2018 Jan 30;115(5):E1002-E1011. doi: 10.1073/pnas.1713195115. Epub 2018 Jan 17.

PMID:
29343644
10.

Characterization of Conserved and Novel Septal Factors in Mycobacterium smegmatis.

Wu KJ, Zhang J, Baranowski C, Leung V, Rego EH, Morita YS, Rubin EJ, Boutte CC.

J Bacteriol. 2018 Feb 23;200(6). pii: e00649-17. doi: 10.1128/JB.00649-17. Print 2018 Mar 15.

PMID:
29311277
11.

Tuberculosis: Just the FAQs.

Guinn KM, Rubin EJ.

MBio. 2017 Dec 19;8(6). pii: e01910-17. doi: 10.1128/mBio.01910-17.

12.

Towards the use of breath for detecting mycobacterial infection: a case study in a murine model.

Franchina FA, Mellors TR, Aliyeva M, Wagner J, Daphtary N, Lundblad LKA, Fortune SM, Rubin EJ, Hill JE.

J Breath Res. 2018 Feb 7;12(2):026008. doi: 10.1088/1752-7163/aaa016.

PMID:
29219122
13.

Report on the Third FDA-AACR Oncology Dose-Finding Workshop.

Emens LA, Bruno R, Rubin EH, Jaffee EM, McKee AE.

Cancer Immunol Res. 2017 Dec;5(12):1058-1061. doi: 10.1158/2326-6066.CIR-17-0590.

PMID:
29196440
14.

The surprising costs of silence: Asymmetric preferences for prosocial lies of commission and omission.

Levine E, Hart J, Moore K, Rubin E, Yadav K, Halpern S.

J Pers Soc Psychol. 2018 Jan;114(1):29-51. doi: 10.1037/pspa0000101. Epub 2017 Nov 2.

PMID:
29094962
15.

An Antibacterial β-Lactone Kills Mycobacterium tuberculosis by Disrupting Mycolic Acid Biosynthesis.

Lehmann J, Cheng TY, Aggarwal A, Park AS, Zeiler E, Raju RM, Akopian T, Kandror O, Sacchettini JC, Moody DB, Rubin EJ, Sieber SA.

Angew Chem Int Ed Engl. 2018 Jan 2;57(1):348-353. doi: 10.1002/anie.201709365. Epub 2017 Dec 5.

PMID:
29067779
16.

The future of DNA sequencing.

Green ED, Rubin EM, Olson MV.

Nature. 2017 Oct 11;550(7675):179-181. doi: 10.1038/550179a. No abstract available.

PMID:
29022931
17.

We Can Do Better - Improving Outcomes in the Midst of an Emergency.

Baden LR, Rubin EJ, Morrissey S, Farrar JJ, Drazen JM.

N Engl J Med. 2017 Oct 12;377(15):1482-1484. doi: 10.1056/NEJMe1712330. No abstract available.

18.

Screen for Disordered Eating: Improving the accuracy of eating disorder screening in primary care.

Maguen S, Hebenstreit C, Li Y, Dinh JV, Donalson R, Dalton S, Rubin E, Masheb R.

Gen Hosp Psychiatry. 2018 Jan - Feb;50:20-25. doi: 10.1016/j.genhosppsych.2017.09.004. Epub 2017 Sep 27.

PMID:
28987918
19.

Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement.

Kim ES, Bruinooge SS, Roberts S, Ison G, Lin NU, Gore L, Uldrick TS, Lichtman SM, Roach N, Beaver JA, Sridhara R, Hesketh PJ, Denicoff AM, Garrett-Mayer E, Rubin E, Multani P, Prowell TM, Schenkel C, Kozak M, Allen J, Sigal E, Schilsky RL.

J Clin Oncol. 2017 Nov 20;35(33):3737-3744. doi: 10.1200/JCO.2017.73.7916. Epub 2017 Oct 2.

PMID:
28968170
20.

Modernizing Clinical Trial Eligibility: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Minimum Age Working Group.

Gore L, Ivy SP, Balis FM, Rubin E, Thornton K, Donoghue M, Roberts S, Bruinooge S, Ersek J, Goodman N, Schenkel C, Reaman G.

J Clin Oncol. 2017 Nov 20;35(33):3781-3787. doi: 10.1200/JCO.2017.74.4144. Epub 2017 Oct 2.

PMID:
28968169
21.

Critical Assessment of Metagenome Interpretation-a benchmark of metagenomics software.

Sczyrba A, Hofmann P, Belmann P, Koslicki D, Janssen S, Dröge J, Gregor I, Majda S, Fiedler J, Dahms E, Bremges A, Fritz A, Garrido-Oter R, Jørgensen TS, Shapiro N, Blood PD, Gurevich A, Bai Y, Turaev D, DeMaere MZ, Chikhi R, Nagarajan N, Quince C, Meyer F, Balvočiūtė M, Hansen LH, Sørensen SJ, Chia BKH, Denis B, Froula JL, Wang Z, Egan R, Don Kang D, Cook JJ, Deltel C, Beckstette M, Lemaitre C, Peterlongo P, Rizk G, Lavenier D, Wu YW, Singer SW, Jain C, Strous M, Klingenberg H, Meinicke P, Barton MD, Lingner T, Lin HH, Liao YC, Silva GGZ, Cuevas DA, Edwards RA, Saha S, Piro VC, Renard BY, Pop M, Klenk HP, Göker M, Kyrpides NC, Woyke T, Vorholt JA, Schulze-Lefert P, Rubin EM, Darling AE, Rattei T, McHardy AC.

Nat Methods. 2017 Nov;14(11):1063-1071. doi: 10.1038/nmeth.4458. Epub 2017 Oct 2.

PMID:
28967888
22.

A 2-in-1 adaptive phase 2/3 design for expedited oncology drug development.

Chen C, Anderson K, Mehrotra DV, Rubin EH, Tse A.

Contemp Clin Trials. 2018 Jan;64:238-242. doi: 10.1016/j.cct.2017.09.006. Epub 2017 Sep 28.

PMID:
28966137
23.

A comprehensive characterization of PncA polymorphisms that confer resistance to pyrazinamide.

Yadon AN, Maharaj K, Adamson JH, Lai YP, Sacchettini JC, Ioerger TR, Rubin EJ, Pym AS.

Nat Commun. 2017 Sep 19;8(1):588. doi: 10.1038/s41467-017-00721-2.

24.

Dose Finding Versus Speed in Seamless Immuno-Oncology Drug Development.

Mayawala K, Tse A, Rubin EH, Jain L, de Alwis DP.

J Clin Pharmacol. 2017 Oct;57 Suppl 10:S143-S145. doi: 10.1002/jcph.1001. No abstract available.

PMID:
28921649
25.

Immuno-oncology Clinical Trial Design: Limitations, Challenges, and Opportunities.

Baik CS, Rubin EH, Forde PM, Mehnert JM, Collyar D, Butler MO, Dixon EL, Chow LQM.

Clin Cancer Res. 2017 Sep 1;23(17):4992-5002. doi: 10.1158/1078-0432.CCR-16-3066.

26.

From Famine to Feast: Developing Early-Phase Combination Immunotherapy Trials Wisely.

Day D, Monjazeb AM, Sharon E, Ivy SP, Rubin EH, Rosner GL, Butler MO.

Clin Cancer Res. 2017 Sep 1;23(17):4980-4991. doi: 10.1158/1078-0432.CCR-16-3064.

27.

Draft Genome Sequence of Mycobacterium avium 11.

Yee M, Klinzing D, Wei JR, Gengenbacher M, Rubin EJ, Chien JY, Hsueh PR, Dick T.

Genome Announc. 2017 Aug 10;5(32). pii: e00766-17. doi: 10.1128/genomeA.00766-17.

28.

Gene and transcript abundances of bacterial type III secretion systems from the rumen microbiome are correlated with methane yield in sheep.

Kamke J, Soni P, Li Y, Ganesh S, Kelly WJ, Leahy SC, Shi W, Froula J, Rubin EM, Attwood GT.

BMC Res Notes. 2017 Aug 8;10(1):367. doi: 10.1186/s13104-017-2671-0.

29.

Development of a Novel Lead that Targets M. tuberculosis Polyketide Synthase 13.

Aggarwal A, Parai MK, Shetty N, Wallis D, Woolhiser L, Hastings C, Dutta NK, Galaviz S, Dhakal RC, Shrestha R, Wakabayashi S, Walpole C, Matthews D, Floyd D, Scullion P, Riley J, Epemolu O, Norval S, Snavely T, Robertson GT, Rubin EJ, Ioerger TR, Sirgel FA, van der Merwe R, van Helden PD, Keller P, Böttger EC, Karakousis PC, Lenaerts AJ, Sacchettini JC.

Cell. 2017 Jul 13;170(2):249-259.e25. doi: 10.1016/j.cell.2017.06.025. Epub 2017 Jun 29.

30.

Reviving a Drug for Tuberculosis?

Rubin EJ.

N Engl J Med. 2017 Jun 8;376(23):2292-2294. doi: 10.1056/NEJMcibr1703502. No abstract available.

PMID:
28591540
31.

Deletion of a mycobacterial divisome factor collapses single-cell phenotypic heterogeneity.

Rego EH, Audette RE, Rubin EJ.

Nature. 2017 Jun 1;546(7656):153-157. doi: 10.1038/nature22361. Epub 2017 May 31.

32.

Strategies to Maximize Patient Participation in Clinical Trials.

Rubin EH, Scroggins MJ, Goldberg KB, Beaver JA.

Am Soc Clin Oncol Educ Book. 2017;37:216-221. doi: 10.14694/EDBK_179803.

33.

Draft Genome Sequence of Mycobacterium abscessus Bamboo.

Yee M, Klinzing D, Wei JR, Gengenbacher M, Rubin EJ, Dick T.

Genome Announc. 2017 May 18;5(20). pii: e00388-17. doi: 10.1128/genomeA.00388-17.

34.

An Official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice Guideline: Mechanical Ventilation in Adult Patients with Acute Respiratory Distress Syndrome.

Fan E, Del Sorbo L, Goligher EC, Hodgson CL, Munshi L, Walkey AJ, Adhikari NKJ, Amato MBP, Branson R, Brower RG, Ferguson ND, Gajic O, Gattinoni L, Hess D, Mancebo J, Meade MO, McAuley DF, Pesenti A, Ranieri VM, Rubenfeld GD, Rubin E, Seckel M, Slutsky AS, Talmor D, Thompson BT, Wunsch H, Uleryk E, Brozek J, Brochard LJ; American Thoracic Society, European Society of Intensive Care Medicine, and Society of Critical Care Medicine.

Am J Respir Crit Care Med. 2017 May 1;195(9):1253-1263. doi: 10.1164/rccm.201703-0548ST. Erratum in: Am J Respir Crit Care Med. 2017 Jun 1;195(11):1540.

PMID:
28459336
35.

States Worse Than Death-Reply.

Rubin EB.

JAMA Intern Med. 2017 Apr 1;177(4):593-594. doi: 10.1001/jamainternmed.2016.9666. No abstract available.

PMID:
28384766
36.

How many tumor indications should be initially screened in development of next generation immunotherapies?

Chen C, Deng Q, He L, Mehrotra DV, Rubin EH, Beckman RA.

Contemp Clin Trials. 2017 Aug;59:113-117. doi: 10.1016/j.cct.2017.03.012. Epub 2017 Mar 21.

PMID:
28341249
37.

Differential Gene Expression in Five Isolates of the Clam Pathogen, Quahog Parasite Unknown (QPX).

Rubin E, Tanguy A, Pales Espinosa E, Allam B.

J Eukaryot Microbiol. 2017 Sep;64(5):647-654. doi: 10.1111/jeu.12400. Epub 2017 Mar 10.

PMID:
28171698
38.

Programmable transcriptional repression in mycobacteria using an orthogonal CRISPR interference platform.

Rock JM, Hopkins FF, Chavez A, Diallo M, Chase MR, Gerrick ER, Pritchard JR, Church GM, Rubin EJ, Sassetti CM, Schnappinger D, Fortune SM.

Nat Microbiol. 2017 Feb 6;2:16274. doi: 10.1038/nmicrobiol.2016.274.

39.

Comprehensive Essentiality Analysis of the Mycobacterium tuberculosis Genome via Saturating Transposon Mutagenesis.

DeJesus MA, Gerrick ER, Xu W, Park SW, Long JE, Boutte CC, Rubin EJ, Schnappinger D, Ehrt S, Fortune SM, Sassetti CM, Ioerger TR.

MBio. 2017 Jan 17;8(1). pii: e02133-16. doi: 10.1128/mBio.02133-16.

40.

PCM-SABRE: a platform for benchmarking and comparing outcome prediction methods in precision cancer medicine.

Eyal-Altman N, Last M, Rubin E.

BMC Bioinformatics. 2017 Jan 17;18(1):40. doi: 10.1186/s12859-016-1435-5.

41.

Early-Onset Invasive Candidiasis in Extremely Low Birth Weight Infants: Perinatal Acquisition Predicts Poor Outcome.

Barton M, Shen A, O'Brien K, Robinson JL, Davies HD, Simpson K, Asztalos E, Langley J, Le Saux N, Sauve R, Synnes A, Tan B, de Repentigny L, Rubin E, Hui C, Kovacs L, Yau YC, Richardson SE; Paediatric Investigators Collaborative Network on Infections in Canada (PICNIC).

Clin Infect Dis. 2017 Apr 1;64(7):921-927. doi: 10.1093/cid/cix001.

PMID:
28077516
42.

Transfer RNAs with novel cloverleaf structures.

Mukai T, Vargas-Rodriguez O, Englert M, Tripp HJ, Ivanova NN, Rubin EM, Kyrpides NC, Söll D.

Nucleic Acids Res. 2017 Mar 17;45(5):2776-2785. doi: 10.1093/nar/gkw898.

43.

A Clinician's Guide to Privacy and Communication in the ICU.

Francis L, Vorwaller MA, Aboumatar H, Frosch DL, Halamka J, Rozenblum R, Rubin E, Lee BS, Sugarman J, Turner K, Brown SM; Privacy, Access, and Engagement Task Force of the Libretto Consortium of the Gordon and Betty Moore Foundation.

Crit Care Med. 2017 Mar;45(3):480-485. doi: 10.1097/CCM.0000000000002190. Review.

PMID:
27922454
44.

PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project.

Hirsch FR, McElhinny A, Stanforth D, Ranger-Moore J, Jansson M, Kulangara K, Richardson W, Towne P, Hanks D, Vennapusa B, Mistry A, Kalamegham R, Averbuch S, Novotny J, Rubin E, Emancipator K, McCaffery I, Williams JA, Walker J, Longshore J, Tsao MS, Kerr KM.

J Thorac Oncol. 2017 Feb;12(2):208-222. doi: 10.1016/j.jtho.2016.11.2228. Epub 2016 Nov 29.

45.

Identification and characterization of peptidases secreted by quahog parasite unknown (QPX), the protistan parasite of hard clams.

Rubin E, Werneburg GT, Pales Espinosa E, Thanassi DG, Allam B.

Dis Aquat Organ. 2016 Nov 22;122(1):21-33.

PMID:
27901501
46.

Progressive Loss of Function in a Limb Enhancer during Snake Evolution.

Kvon EZ, Kamneva OK, Melo US, Barozzi I, Osterwalder M, Mannion BJ, Tissières V, Pickle CS, Plajzer-Frick I, Lee EA, Kato M, Garvin TH, Akiyama JA, Afzal V, Lopez-Rios J, Rubin EM, Dickel DE, Pennacchio LA, Visel A.

Cell. 2016 Oct 20;167(3):633-642.e11. doi: 10.1016/j.cell.2016.09.028.

47.

NKp44 and NKp30 splice variant profiles in decidua and tumor tissues: a comparative viewpoint.

Shemesh A, Kugel A, Steiner N, Yezersky M, Tirosh D, Edri A, Teltsh O, Rosental B, Sheiner E, Rubin E, Campbell KS, Porgador A.

Oncotarget. 2016 Oct 25;7(43):70912-70923. doi: 10.18632/oncotarget.12292.

48.

Rumen metagenome and metatranscriptome analyses of low methane yield sheep reveals a Sharpea-enriched microbiome characterised by lactic acid formation and utilisation.

Kamke J, Kittelmann S, Soni P, Li Y, Tavendale M, Ganesh S, Janssen PH, Shi W, Froula J, Rubin EM, Attwood GT.

Microbiome. 2016 Oct 19;4(1):56.

49.

Genome-wide compendium and functional assessment of in vivo heart enhancers.

Dickel DE, Barozzi I, Zhu Y, Fukuda-Yuzawa Y, Osterwalder M, Mannion BJ, May D, Spurrell CH, Plajzer-Frick I, Pickle CS, Lee E, Garvin TH, Kato M, Akiyama JA, Afzal V, Lee AY, Gorkin DU, Ren B, Rubin EM, Visel A, Pennacchio LA.

Nat Commun. 2016 Oct 5;7:12923. doi: 10.1038/ncomms12923.

50.

Next-Generation High-Throughput Functional Annotation of Microbial Genomes.

Baric RS, Crosson S, Damania B, Miller SI, Rubin EJ.

MBio. 2016 Oct 4;7(5). pii: e01245-16. doi: 10.1128/mBio.01245-16.

Supplemental Content

Support Center